Product category:
Laboratory and scientific consultancy services
News Release from: Chelsea Technologies
Edited by the Laboratorytalk Editorial
Team on 13 December 2006
Helping clients get their product to
market faster
The ever-increasing commercial pressures for rapid product development create significant technical and financial risks; finding an experienced development and manufacturing partner can mitigate these
Chelsea Technologies claims over 35 years experience in the design, development and manufacture of medical diagnostic and scientific instrumentation - from high volume, low cost point of care instruments through to fully automated laboratory analysis systems This experience has been gained by working in partnership with clients across the industry - ranging from technology start-ups to large multi-nationals
This article was originally published on Laboratorytalk on 24 Feb 2003 at 8.00am (UK)
Related stories
First spinal study of bone substitute
Study will measure performance of synthetic bone graft substitute in 30 patients undergoing spinal fusion for degenerative disc disease
Acquisition creates global CRO
Advanced Clinical Sciences becomes a global player in clinical research with the takeover of a Swiss CRO called CRC
John Attridge, life science director said: "Our expertise and practical experience in the design, development and manufacture of analytical instruments made us an ideal partner to work with Osmetech Molecular Diagnostics to develop the Opti Gene, an innovative, rapid and flexible PCR system which will enable genetic testing to be performed in the near point of care market".
The Opti Gene uses proven, well-accepted PCR technology.
The development challenge for Chelsea Technologies was to design a cost effective system that would provide a random access capability and fully independent thermal cycling of up to 12 sample tubes.
Further reading
Achema 2003 - world forum for process industries
27th International exhibition and congress on chemical engineering, environmental protection, and biotechnology
Achema rises to market challenge
Despite the economic uncertainty of the time, the mammoth process industries event in Frankfurt this May will be almost as big as the last record-breaking event, in 2000
A novel, non-imaging, optics design was developed to allow a sensitive fluorescence measurement to be taken from each sample tube in real-time.
Full connectivity was achieved by embedding a PC card in the instrument, which allowed an intuitive graphic user interface to be presented on a touch panel LCD display.
Chelsea Technologies designed all aspects of the system from moulded consumables, electronics, embedded and user interface software, electro-optics and the mechanical design.
Chelsea Technologies is also working with Imperial College and MicroTest Matrices to develop a robust, competitively priced fluorescence reader for micro-arrays that will enable this exciting technology to move out of the research laboratory into commercial diagnostics markets.
Chelsea Technologies has designed a small electro-optics module that illuminates each micro-array spot in turn and also collects the fluorescence generated to produce a single integrated signal value.
This approach significantly reduces the amount of data generated and also the processing power required to analyse conventional scanned images.
Using this approach it is possible to produce results that are comparable to commercial scanning systems but at a fraction of the cost.
Chelsea Technologies is currently integrating the technology into a robust portable assay processing system for the rapid detection of infectious agents that can be deployed in the event of unexplained clusters of acute febrile illness/fatality or a potential terrorist incident.
• Chelsea Technologies: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
